Your search for ‘Buchanan Ingersoll & Rooney PC’ returned 14 results

Sean Girdwood, shareholder and co-chair of Buchanan's Finance Industry Team, is quoted in the Pittsburgh Business Times article, "SBA's latest PPP guidance cuts both ways for lenders"

Richard Fox, shareholder in the firm's Tax section, comments on a relief fund he helped established for the Union League to provide financial assistance to its employees who lost their...

Virus Upends Tax Planning for Companies Facing Sudden Losses.

On the evening of September 30, 2020, President Trump signed into law an appropriations bill that includes, among other provisions...

But the authorization will end 60 days after the expiration of the governor's COVID-19 Disaster Emergency Order.

On May 22, 2025, the U.S. House of Representatives advanced its version of the legislation now known as "The One, Big, Beautiful Bill" (the "Bill") by approving tax provisions...

On June 4, 2025, the Congressional Budget Office (CBO) released its full score of H.R. 1, the One Big Beautiful Bill Act, which House Republicans passed on a 215-214 party-line vote on May 22.

COVID-19 has taken a massive toll on many different industries over the past months. But while the true long-term effects are still unknown, it's possible some businesses may emerge unscathed, and may be even better off ...

On January 26, the U.S. Food and Drug Administration (FDA or the Agency) announced that it is prepared to work with Congress to develop a new regulatory pathway for cannabidiol (CBD).

On the second episode of Buchanan Ingersoll & Rooney's Tax Facts podcast, Becky Lando and Michelle Yarbrough Korb discuss the latest in the utilization of low-income housing tax credits...

On September 10-11, the American Conference Institute (ACI) held its inaugural Animal Health and Veterinary Drugs and Therapeutics Conference in New York City.

I attended the first ever Legal, Regulatory and Compliance Forum on Animal Health and Veterinary Drugs and Therapeutics, "a comprehensive guide to the latest developments affecting drugs for companion animals and livestock".